Description
Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring neuropeptide first isolated from the brain in the 1970s. Research interest centers on its role in sleep regulation, circadian rhythm balance, stress response, and recovery support.
Benefits
- Sleep regulation — studied for promoting deeper, more restorative sleep phases.
- Stress response — linked to modulation of stress-related neuroendocrine activity.
- Circadian rhythm balance — explored for normalizing disrupted sleep–wake cycles.
- Recovery support — interest in improved resilience and recovery in fatigue models.
- Neuromodulation — early research suggests possible interactions with opioid and NMDA pathways.
What researchers look at
- Regulation of sleep architecture, delta-wave activity, and circadian rhythms.
- Interaction with corticotropin and stress hormone pathways.
- Modulation of opioid peptide activity and pain-related signaling.
- Potential antioxidant and neuroprotective roles in preclinical models.
Quick Specs
- Form: Lyophilized peptide
- Net per vial: 5 mg
- Purity: ≥99% (HPLC)
- Identity: MS-verified (per COA)
- Storage: 2–8 °C, protect from light
Identity Basics
- Sequence: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu
- Formula / M.W.: C35H48N10O15, ~848.8 g/mol
- CAS: 62568-57-4
Selected Research
- PubChem entry — chemical identity & registry:
https://pubchem.ncbi.nlm.nih.gov/compound/DSIP
- Original discovery (1977) — isolation and initial findings:
https://pubmed.ncbi.nlm.nih.gov/195032/
- Sleep studies review — DSIP in sleep regulation:
https://pubmed.ncbi.nlm.nih.gov/17184943/
- Neuroendocrine effects — corticotropin and stress hormone pathways:
https://pubmed.ncbi.nlm.nih.gov/16529992/
⚠️ Disclaimer
-
This product is intended for laboratory research use only.
-
Not for human or veterinary use.
-
Not approved for diagnostic, therapeutic, or medical applications.
-
Handle using appropriate laboratory safety procedures and personal protective equipment.
